MARK THOMAS / SCIENCE PHOTO LIBRARY MARK THOMAS / SCIENCE PHOTO LIBRARY
Sativex multiple sclerosis drug. Patient holding a Sativex spray. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. It is also being trialled as a pain control drug for cancer patients.
Model release not required. Property release not available.